NYSE · RXO

RXO, Inc.

$25.63 -$2.14 (-7.71%) 1D After hours

Key Metrics

$4.58B
Market cap
P/E · TTM
$5.73B
Revenue · TTM
−$105.00M
Net income
EPS · TTM $-0.62
Dividend yield
Free cash flow −$15.00M
Beta · 1Y 2.03
EBITDA · TTM −$15.00M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 7
    The stock moved +17.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • Mar 16
    From its Feb 4 high, the share price fell 30%.

    Peak close $17.05 on Feb 4; trough close $11.96 on Mar 16. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -30%
  • Feb 12
    The stock moved -20.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 12

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$4.58B
Enterprise value$5.01B
Shares outstanding164.9M
52-wk range$10.43 – $29.90
Avg volume · 20D1.4M
Net cash −$426.00M
Book value / share$8.98
IndustryTransportation Services
ExchangeNYSE
About RXO, Inc.
IPO dateOct 27, 2022
Employees9218

RXO Inc is a brokered transportation platform defined by technology and a nimble, asset-light business model, with the component being core truck brokerage business.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.80
P/FCF
EV/EBITDA
EV/Sales0.87
Graham №

Profitability

Gross
Operating -2.2%
Net -1.8%
FCF -0.3%
ROE / ROIC -6.7% · -5.4%

Financial Health

Current ratio1.27
Quick ratio
Debt / equity0.30
Debt / EBITDA -29.80
Net cash −$426.00M
Working capital$287.00M

Cash Flow · TTM

Operating CF $46.00M
Capex −$61.00M
Free cash flow −$15.00M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

5 / 9
Middling fundamentals · 5 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings